Stay updated on Pembrolizumab Combo in Premenopausal HR+/HER2- Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Premenopausal HR+/HER2- Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Premenopausal HR+/HER2- Breast Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The study has expanded to include 208 locations and has been updated from revision v2.9.7 to v2.10.0.
    Difference
    0.2%
    Check dated 2024-07-23T16:02:10.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.0%
    Check dated 2024-07-16T09:33:37.000Z thumbnail image
  7. Check
    16 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2024-07-11T01:40:29.000Z thumbnail image
  8. Check
    17 days ago
    Change Detected
    Summary
    The website now shows 'Results Submitted' instead of 'No Results Posted', indicating that there has been progress or activity on the site.
    Difference
    0.2%
    Check dated 2024-07-10T00:56:41.000Z thumbnail image
  9. Check
    24 days ago
    Change Detected
    Summary
    The value Ovarian Epithelial Cancer Fallopian Tube Cancer has recently changed to Fallopian Tube Cancer Ovarian Epithelial Cancer. This change represents a reversal in the order of the terms, with 'Fallopian Tube Cancer' now being mentioned before 'Ovarian Epithelial Cancer.'
    Difference
    0.2%
    Check dated 2024-07-03T15:36:15.000Z thumbnail image
  10. Check
    25 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the webpage content.
    Difference
    0.0%
    Check dated 2024-07-02T15:10:14.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Premenopausal HR+/HER2- Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Premenopausal HR+/HER2- Breast Cancer Clinical Trial page.